Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus
Open Access
- 13 May 2022
- journal article
- research article
- Published by BMJ in Lupus Science & Medicine
- Vol. 9 (1) , e000631
Abstract
Objectives The renal activity index for lupus (RAIL) measures lupus nephritis (LN) activity considering urine levels of 6 biomarkers (neutrophil gelatinase-associated lipocalin, monocyte chemoattractant protein-1, kidney injury molecule-1, adiponectin, haemopexin, ceruloplasmin). We aimed to compare the accuracy of the RAIL and the renal domain-score of the SLE disease activity index (rSLEDAI) in detecting LN activity. Methods Random urine samples of patients with childhood-onset SLE with and without LN were assayed and scores of the RAIL, and RAIL standardised for urine creatinine (RAIL-Cr) were calculated. Clinical LN activity was measured by the rSLEDAI, and histological activity of LN was categorised as inactive/low-moderate/high for National Institute of Health-activity index scores of 10, respectively. Results 115 patients were included in the analysis (47 patients without and 68 with LN). RAIL, RAIL-Cr and rSLEDAI scores at the time (±3 months) of kidney biopsy were available for 32 patients. Median rSLEDAI, RAIL and RAIL-Cr values were 4, –0.04, 0.02 for inactive LN, 12, 0.7 and 0.9 for low-moderate LN activity and 12, 2 and 1.8 for high LN activity, respectively. The area under the receiver operating characteristic curve (AUC) to capture high LN activity was the lowest for the rSLEDAI (AUC=0.62), followed by the RAIL-Cr (AUC=0.73) and RAIL (AUC=0.79). Notably, when testing urine samples collected during routine clinic visits remote (>3 months) from a kidney biopsy, 50% patients with rSLEDAI scores of 0 had RAIL scores reflecting low-moderate LN activity. Conclusion Monitoring of renal inflammation in children and adolescents with SLE can be improved by the measurement of urine biomarkers. The RAIL may constitute important auxiliary tool for the surveillance of LN in a clinical setting and assist with the decision to obtain a kidney biopsy.Keywords
This publication has 33 references indexed in Scilit:
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis & Rheumatism, 2011
- Urinary Biomarkers in Lupus NephritisClinical Reviews in Allergy & Immunology, 2010
- Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activityArthritis & Rheumatism, 2009
- Initial Validation of a Novel Protein Biomarker Panel for Active Pediatric Lupus NephritisPediatric Research, 2009
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohortRheumatology, 2008
- Relationship between Albuminuria and Total Proteinuria in Systemic Lupus Erythematosus NephritisClinical Journal of the American Society of Nephrology, 2008
- Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritisPediatric Nephrology, 2008
- Identification of a urinary proteomic signature for lupus nephritis in childrenPediatric Nephrology, 2007